Clinical Trials Using CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc
Clinical trials are research studies that involve people. The clinical trials on this list are studying CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
A Phase II Trial of CD24Fc for the Prevention of Acute GVHD Following Myeloablative Allogeneic HSCT
This is a multicenter prospective randomized phase IIa / II Expansion clinical trial designed to determine the MTD (Maximum Tolerated Dose) of CD24Fc for acute GVHD (Graft Versus Host Disease) prophylaxis. Funding Source - FDA OOPD
Location: 4 locations